Productivity-cost controversies in cost-effectiveness analysis: review and research agenda
| Autor: | Dev S. Pathak, Elizabeth A. Rothermich |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Pharmacology
Cost–benefit analysis Inclusion (disability rights) Public economics business.industry Cost-Benefit Analysis Cost-effectiveness analysis Efficiency Human capital Quality-adjusted life year Indirect costs Cost of Illness Sickness Impact Profile Medicine Productivity cost Humans Pharmacology (medical) business Productivity |
| Zdroj: | Clinical therapeutics. 21(1) |
| ISSN: | 0149-2918 |
| Popis: | Productivity costs represent true costs to society and should not be ignored in a cost-effectiveness analysis. However, there is dissension among health economists regarding measurement of productivity costs. Certain health economists argue for inclusion of productivity costs in the denominator of the cost-effectiveness ratio, measured in quality-adjusted life-years. Others argue that productivity costs should be included in the numerator of the cost-effectiveness ratio, measured in dollars using the friction-cost method or the human-capital method. This paper reviews the productivity-cost controversies and offers suggestions for future research addressing the debated issues. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect